Indian Patent Application Number: 6960/CHENP/2009 As Amended on 16 November 2017
We Claim
1. A compound which is:
Isobutyric acid (lR*,2R*,4R*)-2-(2-{[3-(4,7-dimethoxy-lH-benzoimidazol-2-yl)-
propyl]-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester;
\ or a pharmaceutically acceptable salt of such a compound.
2. The compound as claimed in claim 1 which is:
Isobutyric acid (lR,2R,4R)-2-(2-{ [3-(4,7-dimethoxy- lH-benzoimidazol-2-yl)-
propyl]-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester:
or
Isobutyric acid (lS,2S,4S)-2-(2-{[3-(4,7-dimethoxy-lH-benzoimidazol-2-yl)-propyl]-
methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester:
146

Indian Patent Application Number: 6960/CHENP/2009 As Amended on 16 November 2017
or a pharmaceutically acceptable salt of such a compound.
3. The compound as claimed in claim 1, which is:
Isobutyric acid (lR,2R,4R)-2-(2-{[3-(4,7-dimethoxy-lH-benzoimidazol-2-yl)-
propyl]-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester:
or a pharmaceutically acceptable salt thereof.
4. A pharmaceutical composition containing, as active principle, a compound as claimed in any one of claims 1 to 3, or a pharmaceutically acceptable salt thereof, and at least one therapeutically inert excipient.